School of Chemistry, University of East Anglia, Norwich, NR4 7TJ, United Kingdom.
Sorbonne Universités, UPMC Univ Paris 06, CNRS, Institut Parisien de Chimie Moléculaire (IPCM), 4 Place Jussieu, 75005, Paris, France.
Chemistry. 2018 Aug 14;24(46):11840-11851. doi: 10.1002/chem.201800981. Epub 2018 Jun 8.
Gold(III) complexes have emerged as a versatile and effective class of metal-based anticancer agents. The development of various types of ligands capable of stabilizing the Au cation and preventing its reduction under physiological conditions, such as chelating nitrogen-donors, dithiocarbamates and C^N cyclometalled ligands, has opened the way for the exploration of their potential intracellular targets and action mechanisms. At the same time, the bioconjugation of Au complexes has emerged as a promising strategy for improving the selectivity of this class of compounds for cancer cells over healthy tissues, and recent developments have shown that combining gold complexes with molecular structures that are specifically recognized by the cell can exploit the cell's own transport mechanisms to improve selective metal uptake.
金(III)配合物已成为一类多功能且有效的基于金属的抗癌药物。各种类型的配体的开发能够稳定 Au 阳离子并防止其在生理条件下还原,例如螯合氮供体、二硫代氨基甲酸盐和 C^N 环金属化配体,为探索其潜在的细胞内靶标和作用机制开辟了道路。同时,金配合物的生物缀合已成为提高此类化合物对癌细胞相对于健康组织的选择性的一种很有前途的策略,最近的研究表明,将金配合物与被细胞特异性识别的分子结构相结合,可以利用细胞自身的转运机制来提高金属的选择性摄取。